United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

noumed life sciences ltd - erythromycin - gastro-resistant tablet - 250mg

Canada - English - Health Canada

aa pharma inc - erythromycin (erythromycin ethylsuccinate) - tablet - 600mg - erythromycin (erythromycin ethylsuccinate) 600mg - erythromycins

Canada - English - Health Canada

amdipharm limited - erythromycin (erythromycin ethylsuccinate) - tablet - 600mg - erythromycin (erythromycin ethylsuccinate) 600mg - erythromycins

Canada - English - Health Canada

amdipharm limited - erythromycin (erythromycin ethylsuccinate) - powder for suspension - 400mg - erythromycin (erythromycin ethylsuccinate) 400mg - erythromycins

Canada - English - Health Canada

amdipharm limited - erythromycin (erythromycin ethylsuccinate) - powder for suspension - 40mg - erythromycin (erythromycin ethylsuccinate) 40mg - erythromycins

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - erythromycin ethylsuccinate 46.8 mg/ml equivalent to erythromycin 40 mg/ml (does not include 10% overage) - granules for oral suspension - 200 mg/5ml - active: erythromycin ethylsuccinate 46.8 mg/ml equivalent to erythromycin 40 mg/ml (does not include 10% overage) excipient: aspartame cherry flavour 163837 colloidal silicon dioxide erythrosine propylene glycol alginate sodium benzoate sodium citrate dihydrate sorbitol - streptococcus pyogenes (group a beta-haemolytic streptococcus): upper and lower respiratory tract, skin and soft tissue infections of mild to moderate severity. when oral medication is preferred for treatment of streptococcal pharyngitis and in long term prophylaxis of rheumatic fever, erythromycin is an alternate drug of choice. when oral medication is given, the importance of strict adherence by the patient to the prescribed dosage regimen must be stressed. a therapeutic dose should be administered for at least 10 days. prevention of initial attacks of rheumatic fever: penicillin is considered to be the drug of choice in the prevention of initial attacks of rheumatic fever (treatment of group a beta-haemolytic streptococcal infections of the upper respiratory tract e.g. tonsillitis or pharyngitis). erythromycin is indicated for the treatment of penicillin-allergic patients. the therapeutic dose should be administered for 10 days. prevention of recurrent attacks of rheumatic fever: penicillin or sulphonamides are considered to be the drugs of choice in the prevention of recurrent attacks of rheumatic fever. in patients who are allergic to penicillin and sulphonamides, oral erythromycin is recommended in the long term prophylaxis of streptococcal pharyngitis (for the prevention of recurrent attacks of rheumatic fever).

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - erythromycin ethylsuccinate 93.6 mg/ml equivalent to erythromycin 80 mg/ml (does not include 10% overage) - granules for oral suspension - 400 mg/5ml - active: erythromycin ethylsuccinate 93.6 mg/ml equivalent to erythromycin 80 mg/ml (does not include 10% overage) excipient: aspartame cherry flavour 163837 colloidal silicon dioxide erythrosine propylene glycol alginate sodium benzoate sodium citrate dihydrate sorbitol - streptococcus pyogenes (group a beta-haemolytic streptococcus): upper and lower respiratory tract, skin and soft tissue infections of mild to moderate severity. when oral medication is preferred for treatment of streptococcal pharyngitis and in long term prophylaxis of rheumatic fever, erythromycin is an alternate drug of choice. when oral medication is given, the importance of strict adherence by the patient to the prescribed dosage regimen must be stressed. a therapeutic dose should be administered for at least 10 days. prevention of initial attacks of rheumatic fever: penicillin is considered to be the drug of choice in the prevention of initial attacks of rheumatic fever (treatment of group a beta-haemolytic streptococcal infections of the upper respiratory tract e.g. tonsillitis or pharyngitis). erythromycin is indicated for the treatment of penicillin-allergic patients. the therapeutic dose should be administered for 10 days. prevention of recurrent attacks of rheumatic fever: penicillin or sulphonamides are considered to be the drugs of choice in the prevention of recurrent attacks of rheumatic fever. in patients who are allergic to penicillin and sulphonamides, oral erythromycin is recommended in the long term prophylaxis of streptococcal pharyngitis (for the prevention of recurrent attacks of rheumatic fever).

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

arpimed llc - erythromycin (erythromycin ethylsuccinate) - tablets - 400mg

United States - English - NLM (National Library of Medicine)

kaiser foundation hospitals - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - erythromycin 250 mg

United States - English - NLM (National Library of Medicine)

arbor pharmaceuticals, inc. - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - erythromycin 250 mg - erythromycin is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below: upper respiratory tract infections of mild to moderate degree caused by streptococcus pyogenes, streptococcus pneumoniae, or haemophilus influenzae (when used concomitantly with adequate doses of sulfonamides, since many strains of h. influenzae are not susceptible to the erythromycin concentrations ordinarily achieved). (see appropriate sulfonamide labeling for prescribing information). lower respiratory tract infections of mild to moderate severity caused by streptococcus pneumoniae or streptococcus pyogenes . listeriosis caused by listeria monocytogenes . pertussis (whooping cough) caused by bordetella pertussis . erythromycin is effective in eliminating the organism from the nasopharynx of infected individuals rendering them noninfectious. some clinical studies suggest that erythromycin may be helpful in the prophylaxis of pertussis in exposed susceptible ind